Introduction to special issue on glaucomatous optic neuropathy: In vivo models and techniques

Experimental Eye Research

Volumn 141, Issue , 2015, Pages 1-2

  Ethier, C Ross ^a   Morrison, John C ^b   Clark, Abbott F ^c  

^a Emory University   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Animal models; Glaucoma; Optic nerve; Techniques

Indexed keywords

ANTERIOR EYE CHAMBER; EDITORIAL; GLAUCOMATOUS OPTIC NEUROPATHY; HUMAN; IN VIVO STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NONHUMAN; OPTIC NERVE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; ANIMAL; COMPLICATION; DISEASE MODEL; GLAUCOMA; OPTIC NERVE DISEASES; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; OPTIC NERVE DISEASES;

EID: 84945493964     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.07.017     Document Type: Editorial

References (9)

1. Anderson D.R., Drance S.M., Schulzer M. Natural history of normal-tension glaucoma. Ophthalmology 2001, 108:247-253.
2. Bengtsson B., Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J. Glaucoma 2005, 14:135-138.
3. Epstein D.L., Krug J.H., Hertzmark E., Remis L.L., Edelstein D.J. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology 1989, 96:1460. [see comments].
4. Heijl A., Leske M.C., Bengtsson B., Hyman L., Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch. Ophthalmol. 2002, 120:1268-1279.
5. Investigators A. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 2000, 130:429-440.
6. Kass M.A., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Gordon M.O. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002, 120:701.
7. Leske M.C., Heijl A., Hussein M., Bengtsson B., Hyman L., Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 2003, 121:48-56.
8. Tham Y.-C., Li X., Wong T.Y., Quigley H.A., Aung T., Cheng C.-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014, 121:2081-2090.
9. Weinreb R.N., Khaw P.T. Primary open-angle glaucoma. Lancet 2004, 363:1711-1720.